Hyaluronic Acid-based Dermal Fillers Global Market Report 2024

Hyaluronic acid-based dermal fillers constitute a type of dermal filler designed for short-term use. Hyaluronic acid, known for its ability to attract water to the skin, enhances skin moisturization. Belotero and Restylane Silk, specific types of hyaluronic acid-based fillers, are utilized to address shallow and fine wrinkles, effectively preventing signs of aging.

The primary categories of hyaluronic acid-based dermal fillers include single-phase and duplex products. Single-phase products find widespread application in various skin-related procedures, addressing soft facial tissue irregularities. The uncross-linked hyaluronic acid in these products stimulates elastin and collagen production, resulting in a more youthful and healthier appearance of the skin. These fillers are employed in specialty and dermatology clinics, as well as hospitals, for diverse applications such as wrinkle removal, lip augmentation, rhinoplasty, and other aesthetic procedures.

The hyaluronic acid-based dermal fillers market research report is one of a series of new reports that provides hyaluronic acid-based dermal fillers market statistics, including hyaluronic acid-based dermal fillers industry global market size, regional shares, competitors with a hyaluronic acid-based dermal fillers market share, detailed hyaluronic acid-based dermal fillers market segments, market trends and opportunities, and any further data you may need to thrive in the hyaluronic acid-based dermal fillers industry. This hyaluronic acid-based dermal fillers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyaluronic acid-based dermal fillers market size has grown rapidly in recent years. It will grow from $4.47 billion in 2023 to $5 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period can be credited to factors such as the aging population, an increase in beauty consciousness, the influence of social media, the proliferation of medical spas and aesthetic clinics, and the surge in e-commerce activities.

The hyaluronic acid-based dermal fillers market size is expected to see rapid growth in the next few years. It will grow to $7.64 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period can be linked to factors such as the rise in disposable income, heightened consumer awareness about personal hygiene and grooming, an increasing demand for personal care products, and overall economic growth. Key trends expected in the forecast period encompass the adoption of natural and organic formulations, the exploration of combination therapies, the prevalence of minimally invasive procedures, the advancement of delivery techniques, and the integration of virtual consultations and telemedicine in the industry.

The growth of hyaluronic acid-based dermal fillers is being fueled by an increasing demand for non-invasive dermatology techniques. Unlike invasive tests that break the skin or enter the body, non-invasive treatments, such as those utilizing acid-based dermal fillers, are preferred for their minimal risks and long-lasting results. The American Society of Plastic Surgeons (ASPS) reported in February 2022 that over 17 million adults annually choose cosmetic surgeries, including minimally invasive options like body contouring, lasers, and injections. This rising demand is expected to boost the market for hyaluronic acid-based dermal fillers.

The growth of the hyaluronic acid-based dermal fillers market is further propelled by the increasing aging population. With an aging population characterized by a higher proportion of elderly individuals due to increased life expectancy and declining birth rates, hyaluronic acid-based dermal fillers provide a non-surgical solution for addressing signs of aging such as wrinkles and sagging skin. According to the World Health Organization (WHO), the global population aged 60 and above is projected to double by 2050, reaching 2.1 billion, while those aged 80 and older will triple, reaching 426 million. Consequently, the surge in the aging population is a key driver for the hyaluronic acid-based dermal fillers market.

Technological advancements are playing a crucial role in shaping the hyaluronic acid-based dermal fillers market. Major companies in this sector are actively developing new technological solutions to strengthen their market position. For instance, in 2021, laser resurfacing treatments were introduced as a more efficient and less invasive option addressing multiple skin concerns using lasers. This technological innovation caters to the evolving needs of consumers, making treatments more appealing and capable of addressing various skin problems simultaneously, even coping with stress related to COVID-19.

Mmajor companies in the hyaluronic acid-based dermal fillers market are introducing OxiFree technology. This technology is designed to preserve long molecular hyaluronic acid (HA) chains, ensuring their integrity and effectiveness in various applications. In June 2022, Sinclair Pharma Ltd launched MaiLi, the world's first OxiFree Dermal Filler, incorporating patented OxiFree HA technology. This innovation involves crosslinking through 1,4-Butanediol diglycidyl ether (BDDE), resulting in a pliable, resilient gel known for its voluminous projection and long-lasting properties.

In October 2022, Prollenium Medical Technologies Inc., a Canada-based manufacturer and distributor of hyaluronic acid-based dermal fillers, acquired Soft Medical Aesthetics to enhance their portfolio, featuring Revanesse dermal fillers. The addition of SoftFil, a France-based manufacturer of hyaluronic acid-based dermal fillers, aims to strengthen safety and effectiveness in the field of aesthetic medicine, further expanding Prollenium's presence in the market.

Major companies operating in the hyaluronic acid-based dermal fillers market include Bohus Biotech AB, AbbVie Inc., Galderma Laboratories L.P., Merz Pharmaceuticals GmbH, Genzyme Corporation, Anika Therapeutics Inc., LG Chem Ltd., Bio plus Co. Ltd., Sculpt Luxury Dermal Fillers Ltd., Bioxis Pharmaceutical, Sinclair Pharma PLC, Laboratories Vivacy SAS, Medicis Aesthetics Holdings Inc., Inamed Corporation, Teoxane S.A., Suneva Medical Inc., Advanced Aesthetic Technologies Inc., Croma-Pharma GmbH, Cytophil Inc., DR. Korman Laboratories Ltd., Huons Global Co. Ltd., Revance Therapeutics Inc., Syneron Medical Ltd., TEOXANE Laboratories

North America was the largest region in the hyaluronic acid-based dermal fillers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hyaluronic acid-based dermal fillers market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hyaluronic acid-based dermal fillers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The hyaluronic acid-based dermal fillers market consists of sales of fat grafting, permanent soft tissue filler, poly-l-lactic acid, calcium hydroxylapatite, and hyaluronic acid. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.